Related Experiment Video
Updated: Sep 30, 2026

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
Published on: September 3, 2013
[Localized cancer of the prostate. What to tell the patient?]
1Département de radiothérapie, Institut Gustave-Roussy, 94805 Villejuif, France.
Abstract:
Answering the question from patients with adenocarcinoma of the prostate is always difficult; choice of radiation therapy (versus prostatectomy), indications of brachytherapy frequency and severity of acute and late effects as rate of survival, local control, are among the most frequent inquiries. A part of the answers are not evident of due lack, consensus and the physicians need to speak honestly and give the most appropriate responses without improving anxiety and fears of the patient.
Related Concept Videos
Disorders of the Male Reproductive System
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Cancer Survival Analysis
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

